News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 14 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
-
11 04 2022 Quest Diagnostics (NYSE: DGX) has just unveiled three new fitness panels on questhealth.com, designed for athletes of every kind, from weekend warriors to gold medalists. Each fitness test panel...
11 02 2022 The recognition program honors companies and nonprofits providing people compelling reasons to care about them and offering inspiration for others to buy in SECAUCUS, N.J., Nov. 2, 2022...
-
11 01 2022 DALLAS, November 1, 2022 — According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American. In an effort to address...
-
11 01 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest...
-
10 28 2022 Healthy Houston Collective includes a multipronged approach to addressing key disparities in the Houston area HOUSTON, Oct. 28, 2022 /PRNewswire/ -- Bread of Life, Inc. announced the launch of the...
10 27 2022 Sesame Workshop, the nonprofit educational organization behind Sesame Street which reaches 156 million children across more than 150 countries, and Quest Diagnostics (NYSE: DGX), the world's...
-
10 20 2022 Third quarter revenues of $2.49 billion, down 10.4% from 2021 Third quarter reported diluted earnings per share ("EPS") of $2.17, down 46.0% from 2021; and adjusted diluted EPS of $2.36, down...
-
10 18 2022 Features Nationally Scaled RNA Sequencing and Specimen Collection for Multiple Sclerosis and Non-Alcoholic Fatty Liver Disease with Plans to ExpandDecode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest...
10 13 2022 Quest Diagnostics (NYSE: DGX), the leader in diagnostic testing, unveiled a nationwide campaign, titled "Put Your ___ To The Test." The unexpected, provocative, and fresh campaign empowers...